BREAKING
Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share 15 hours ago Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth 15 hours ago RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares 16 hours ago Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss 16 hours ago CMCT Reports Q4 Loss of $11.20/Share 16 hours ago ACCO Brands adjusted earnings per share of $0.38 for Q4 2025 17 hours ago BREAKING: KFY Reports Q3 Earnings 17 hours ago Vicor (VICR) reported Q4 2025 diluted EPS of $1.01 17 hours ago FN Shares Plunge 10% Despite Earnings Beat as Q1 Revenue Guidance Signals 17.9% Sequential Drop 18 hours ago BREAKING: FCEL Reports Wider Q1 FY26 Loss Than Expected 18 hours ago Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share 15 hours ago Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth 15 hours ago RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares 16 hours ago Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss 16 hours ago CMCT Reports Q4 Loss of $11.20/Share 16 hours ago ACCO Brands adjusted earnings per share of $0.38 for Q4 2025 17 hours ago BREAKING: KFY Reports Q3 Earnings 17 hours ago Vicor (VICR) reported Q4 2025 diluted EPS of $1.01 17 hours ago FN Shares Plunge 10% Despite Earnings Beat as Q1 Revenue Guidance Signals 17.9% Sequential Drop 18 hours ago BREAKING: FCEL Reports Wider Q1 FY26 Loss Than Expected 18 hours ago
INCY

Incyte Corporation

$INCY NASDAQ Mar 10, 2026 BMO FY 2026

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

INCY Coverage

Transcript Incyte Corporation (INCY) Q4 2025 Earnings Call Transcript Mar 10, 2026 Event Incyte Corporation (INCY) Sec Form 8K Mar 7, 2026 Event Incyte Corporation (INCY) Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) Mar 6, 2026 Event Incyte Corporation (INCY) Barclays 28th Annual Global Healthcare Conference Feb 17, 2026 News Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance Feb 10, 2026 Transcript Incyte Corporation (INCY) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Incyte Corporation (INCY) Q3 2025 Earnings Call Transcript Jan 22, 2026